This page shows the latest Ian Read news and features for those working in and with pharma, biotech and healthcare.
We are fortunate to have D. Gottlieb join Pfizer’s Board of Directors,” said Pfizer executive chairman and former CEO Ian Read.
he prepared to take the helm from Ian Read at the start of the year.
The changes reflect a wider reorganisation in Pfizer's US headquarters, where Albert Bourla will succeed Ian Read as CEO of Pfizer on 1 January, plus a reshuffle of the
Pfizer CEO Ian Read said when announcing the increases that “the best means to address affordability of medicines is to reduce the growing out-of-pocket costs that consumers are facing ... Ian Read, Pfizer CEO. There’s a gulf between the tabling of a
If Soriot does want to move on, there aren’t likely to be many vacancies in big pharma any time soon: Pfizer has just announced that Albert Bourla will succeed Ian ... Read as CEO, and Merck &Co have just changed their rules to allow Ken Frazier to
Albert Bourla, incoming Pfizer CEO. Bourla was revealed as CEO less than two weeks ago, after current boss Ian Read announced he would step down from the role after eight years ... Bourla said: “We are at a pivotal moment in Pfizer’s history, with
More from news
Approximately 1 fully matching, plus 54 partially matching documents found.
1. Albert Bourla - Pfizer’s new chief executive. The first entry in our alphabetical list is Albert Bourla, who stepped into the shoes of long-serving Pfizer chief executive Ian Read
CEO Ian Read and AstraZeneca’s Pascal Soriot about the former’s hostile takeover bid in 2014 being the only similar example from recent history.
Bourla was revealed as CEO in early October, after current boss Ian Read announced he would step down from the role after eight years of service. ... Bourla said: “We are at a pivotal moment in Pfizer’s history, with Ian Read having positioned the
At the beginning of the month this was confirmed by Ian Read, CEO of Pfizer. ... During the second quarter earnings call Read said: “We look at BD (business development) as a way of improving returns for shareholders.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
vaccines. Ian Read, chairman and CEO, Pfizer, said: “Albert is a proven and trusted leader with over two decades of leadership experience and a demonstrated track record for delivering strong business
Ian Read, Pfizer's chairman and chief executive officer, said: “We are pleased to welcome Ron Blaylock to Pfizer's board of directors.
Ian Read, IFPMA's president and chief executive and chairman of Pfizer, said: “Thomas has extensive experience in the research-based biopharmaceutical industry and a deep understanding of what is needed
Read succeeds Merck KGaA’s Dr Stefan Oschmann for a two-year term. ... The International Federation of Pharmaceutical Manufacturers &Associations (IFPMA) has elected Pfizer's Ian Read as its new president, succeeding Merck KGaA's Dr Stefan Oschmann.
The addition of Shantanu Narayen to our board helps ensure that Pfizer will continue to benefit from a diversity of experience,” said Ian Read, Pfizer's chairman and CEO.
More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...